Carol Waldo is the Head of Regulatory Affairs at Spero Therapeutics in Cambridge, MA. Ms. Waldo has over 27 years of experience in drug development, including over 17 years of experience in regulatory affairs across a number of therapeutic areas. Her experience spans biologics and small molecules across all stages of development, meetings with regulatory authorities and commercialization. Prior to Spero, Ms. Waldo served as Vice President of Regulatory Affairs at Cubist Pharmaceuticals where her responsibilities included regulatory strategy, advertising, promotion and labeling. Additionally, she worked in regulatory strategy and leadership roles at Amgen, Quintiles and ContraFect.
Ms. Waldo received a bachelor’s degree from North Central College in Naperville, IL.